Tandem Diabetes Care Cash Flow Statement
NASDAQ: TNDMHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Tandem Diabetes Care free cash flow
In fiscal 2025, Tandem Diabetes Care generated -$9.7 million of operating cash flow and spent $19.9 million on capital expenditures. That left free cash flow of -$29.7 million, a free-cash-flow margin of -2.9% of revenue. Free cash flow was down 694.1% from the prior year's $5.0 million.
Summary generated from market data by MetaCap's automated system. Methodology
Tandem Diabetes Care cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -204.71M | -96.03M | -222.61M | -94.59M | 15.57M | -34.38M | -24.75M | -122.61M | -73.03M | -83.45M |
| Net Income growth (YoY) | — | — | — | -707.70% | — | — | — | — | — | — |
| Depreciation & Amortization | 17.67M | 16.61M | 15.71M | 14.33M | 13.85M | 10.45M | 6.07M | 5.82M | 6.87M | 5.49M |
| Stock-Based Compensation | 92.38M | 101.38M | 88.08M | 84.92M | 60.75M | 58.43M | 58.07M | 23.74M | 12.63M | 11.66M |
| Change in Working Capital | -44.31M | -52.13M | -31.72M | -17.95M | -11.98M | -51.73M | -27.68M | -5.86M | -19.16M | 228.00K |
| Operating Cash Flow | -9.72M | 24.23M | -31.81M | 50.46M | 111.36M | 24.67M | 41.91M | -8.32M | -66.14M | -61.17M |
| Capital Expenditures | -19.95M | -19.23M | -26.80M | -34.10M | -14.18M | -27.41M | -19.54M | -2.99M | -5.72M | -8.93M |
| Investing Cash Flow | 72.88M | -23.48M | -85.74M | 33.17M | -186.88M | -296.06M | -56.95M | -90.74M | 2.78M | 10.45M |
| Share Repurchases | 0 | -30.00M | 0 | 0 | — | — | — | — | — | — |
| Financing Cash Flow | -43.37M | 8.37M | 4.11M | 16.88M | 51.93M | 314.44M | 24.21M | 117.18M | 40.38M | 52.31M |
| Net Change in Cash | 21.40M | 10.37M | -113.65M | 101.34M | -23.43M | 43.44M | 9.35M | 18.13M | -22.98M | 1.59M |
| Free Cash Flow | -29.67M | 4.99M | -58.61M | 16.37M | 97.18M | -2.74M | 22.36M | -11.30M | -71.85M | -70.10M |
This table shows 10 annual periods of Tandem Diabetes Care's cash flow statement, from FY 2025 back to FY 2016, across 11 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow TNDM's reporting calendar. What is a cash flow statement?